Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients

S. Wieczorek*, S. Hoffjan, A. Chan, L. Rey, L. Harper, H. Fricke, J. U. Holle, W. L. Gross, J. T. Epplen, P. Lamprecht

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Recently, there has been increasing evidence that a non-synonymous exchange (Gly307Ser) in the gene for CD226 is linked to several autoimmune diseases including type 1 diabetes, multiple sclerosis (MS), rheumatoid arthritis and Grave's disease. Here we present evidence that this polymorphism also predisposes to Wegener's granulomatosis (WG), an autoimmune condition belonging to the group of ANCA (antineutrophil cytoplasmic autoantibody)-associated vasculitides. We found a significant association of the 307Ser allele in separate panels of 520 Northern German (P=0.016, odds ratio (OR)=1.20) and 122 Southern German (P=0.020, OR=1.37) WG cases compared with 1226 healthy controls. The importance of this single-nucleotide polymorphism in the etiopathology of ANCA-associated vasculitides is supported by similar effect sizes that we found in British WG cases (n=105) and German patients with Churg-Strauss syndrome (n=119), which, however, miss significance level because of the relatively small cohorts available for these rare disorders. Finally, we confirm the association with MS in a cohort of 422 German patients (P=0.011, OR=1.23).

OriginalspracheEnglisch
ZeitschriftGenes and Immunity
Jahrgang10
Ausgabenummer6
Seiten (von - bis)591-595
Seitenumfang5
ISSN1466-4879
DOIs
PublikationsstatusVeröffentlicht - 2009

Fördermittel

Funding: This work was supported by the Deutsche Forschungsgemeinschaft (KFO 170 & Excellence cluster Inflammation at Interfaces Research Areas E and JRG I-h) and a FoRUM grant (F601–2007 to S Wieczorek).

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren